Ask AI
ProCE Banner Activity

Safety and Immunogenicity of BNT162b2 COVID-19 Vaccine Among Adults With AIIRD vs the General Population in Israel

Conference Coverage
Slideset
Most DMARDs, including methotrexate, biologics, and JAK inhibitors, can be continued when the BNT162b2 mRNA COVID-19 vaccine is given.

Released: July 30, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Janssen administered by Scientific Affairs